journal article·2023-12

Modes and Mechanisms of Salivary Gland Epithelial Cell Death in Sjogren's Syndrome

Jiannan Zhou, Janak Lal Pathak, Qianwen Liu, Shilin Hu, Tingting Cao, Nobumoto Watanabe, Yongliang Huo, Jiang Li

Advanced Biology· Volume 7· Issue 12
Publisher page

Abstract

Abstract Sjogren's syndrome is an autoimmune disease in middle and old‐aged women with a dry mucosal surface, which is caused by the dysfunction of secretory glands, such as the oral cavity, eyeballs, and pharynx. Pathologically, Sjogren's syndrome are characterized by lymphocyte infiltration into the exocrine glands and epithelial cell destruction caused by autoantibodies Ro/SSA and La/SSB. At present, the exact pathogenesis of Sjogren's syndrome is unclear. Evidence suggests epithelial cell death and the subsequent dysfunction of salivary glands as the main causes of xerostomia. This review summarizes the modes of salivary gland epithelial cell death and their role in Sjogren's syndrome progression. The molecular mechanisms involved in salivary gland epithelial cell death during Sjogren's syndrome as potential leads to treating the disease are also discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Salivary Gland Disorders and Functions · Diabetes and associated disorders · Inflammasome and immune disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Engineering Research Center of Oral Restoration and Reconstruction Affiliated Stomatology Hospital of Guangzhou Medical University Guangzhou Guangdong 510182 China

Chemical Biology Research Group RIKEN Center for Sustainable Resource Science Wako Saitama 351‐0198 Japan

Experimental Animal Center Guangzhou Medical University Guangzhou Guangdong 511436 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1136/annrheumdis-2014-20537510.1136/annrheumdis-2014-205375 ↗
2. 10.1136/bmj.e382110.1136/bmj.e3821 ↗
3. 10.1007/s10067-020-05017-310.1007/s10067-020-05017-3 ↗
4. 10.1016/j.autrev.2018.06.01510.1016/j.autrev.2018.06.015 ↗
5. 10.1038/s41467-021-23472-710.1038/s41467-021-23472-7 ↗
6. 10.3390/ijms23211322910.3390/ijms232113229 ↗
7. 10.1016/j.jaut.2012.01.00210.1016/j.jaut.2012.01.002 ↗
8. 10.1016/j.autrev.2018.05.00510.1016/j.autrev.2018.05.005 ↗
9. 10.1016/j.jaut.2019.10236410.1016/j.jaut.2019.102364 ↗
10. Stefanski A. L. · Dtsch Arztebl Int. · 2017 · 114 · 354
11. C.Vitali N.delPapa 2017 76 1953.10.1136/annrheumdis-2017-211378 ↗
12. 10.3899/jrheum.20090710.3899/jrheum.200907 ↗
13. 10.1016/S0140-6736(05)66990-510.1016/S0140-6736(05)66990-5 ↗
14. 10.1007/s12016-009-8152-z10.1007/s12016-009-8152-z ↗
15. 10.7150/ijms.1771810.7150/ijms.17718 ↗
16. 10.1136/annrheumdis-2016-21044810.1136/annrheumdis-2016-210448 ↗
17. 10.1038/s41584-021-00605-210.1038/s41584-021-00605-2 ↗
18. 10.1038/s41598-021-90569-w10.1038/s41598-021-90569-w ↗
19. 10.1038/s41522-021-00192-w10.1038/s41522-021-00192-w ↗
20. 10.1016/S0952-7915(98)80222-710.1016/S0952-7915(98)80222-7 ↗
21. 10.1128/MCB.06159-1110.1128/MCB.06159-11 ↗
22. 10.1038/ni.223710.1038/ni.2237 ↗
23. 10.1038/s41422-022-00653-710.1038/s41422-022-00653-7 ↗
24. 10.1186/s13046-023-02675-410.1186/s13046-023-02675-4 ↗
25. 10.1016/j.jaut.2023.10301410.1016/j.jaut.2023.103014 ↗
26. 10.1016/j.jaut.2023.10303710.1016/j.jaut.2023.103037 ↗
27. 10.1093/jleuko/qiad04910.1093/jleuko/qiad049 ↗
28. 10.1002/art.4201810.1002/art.42018 ↗
29. 10.1016/j.freeradbiomed.2023.05.02710.1016/j.freeradbiomed.2023.05.027 ↗
30. 10.1016/j.jaut.2022.10289010.1016/j.jaut.2022.102890 ↗
31. Caielli S. · Pathogenesis: Interferon Beyond · 2023 · 41 · 533
32. 10.3389/fimmu.2021.80980610.3389/fimmu.2021.809806 ↗
33. 10.3389/fimmu.2021.78361610.3389/fimmu.2021.783616 ↗
34. 10.1126/science.aah406510.1126/science.aah4065 ↗
35. 10.1038/s41423-020-00630-310.1038/s41423-020-00630-3 ↗
36. 10.1038/nri.2016.15310.1038/nri.2016.153 ↗
37. 10.1038/s41580-020-0270-810.1038/s41580-020-0270-8 ↗
38. Xu X. · Biosci. Rep. · 2019 · 39
39. 10.1053/sarh.2003.5001910.1053/sarh.2003.50019 ↗
40. 10.1093/ecco-jcc/jjw05310.1093/ecco-jcc/jjw053 ↗
41. 10.3390/ijms1802036710.3390/ijms18020367 ↗
42. 10.1016/S0002-9440(10)65111-510.1016/S0002-9440(10)65111-5 ↗
43. 10.1111/cei.1307710.1111/cei.13077 ↗
44. 10.1006/jaut.2001.052410.1006/jaut.2001.0524 ↗
45. 10.3390/ijms1908236910.3390/ijms19082369 ↗
46. Ichikawa Y. · Clin. Exp. Rheumatol. · 1995 · 13 · 307
47. 10.1007/s10495-008-0261-210.1007/s10495-008-0261-2 ↗
48. 10.1016/j.jaut.2010.06.01010.1016/j.jaut.2010.06.010 ↗
49. 10.1016/j.cellsig.2021.11004210.1016/j.cellsig.2021.110042 ↗
50. 10.1080/15548627.2015.110666810.1080/15548627.2015.1106668 ↗
51. 10.1016/j.cell.2019.05.02610.1016/j.cell.2019.05.026 ↗
52. 10.1016/j.arr.2016.07.00110.1016/j.arr.2016.07.001 ↗
53. 10.1016/j.neuron.2022.01.01710.1016/j.neuron.2022.01.017 ↗
54. 10.1080/15548627.2018.149148910.1080/15548627.2018.1491489 ↗
55. 10.1016/j.mam.2021.10102010.1016/j.mam.2021.101020 ↗
56. 10.1242/jcs.24632210.1242/jcs.246322 ↗
57. 10.1016/j.ceb.2010.10.00910.1016/j.ceb.2010.10.009 ↗
58. 10.3390/cells1108135910.3390/cells11081359 ↗
59. 10.1016/j.jaut.2023.10303010.1016/j.jaut.2023.103030 ↗
60. 10.1038/s41598-020-71669-510.1038/s41598-020-71669-5 ↗
61. 10.3389/fimmu.2018.0151210.3389/fimmu.2018.01512 ↗
62. 10.1016/j.jaut.2018.02.00510.1016/j.jaut.2018.02.005 ↗
63. 10.1093/rheumatology/keaa67010.1093/rheumatology/keaa670 ↗
64. 10.1096/fj.202200946R10.1096/fj.202200946R ↗
65. 10.1016/j.cell.2007.10.03510.1016/j.cell.2007.10.035 ↗
66. 10.1016/j.cell.2010.01.02810.1016/j.cell.2010.01.028 ↗
67. 10.1038/s41573-021-00154-z10.1038/s41573-021-00154-z ↗
68. 10.1038/s41392-021-00507-510.1038/s41392-021-00507-5 ↗
69. 10.1016/j.tcb.2017.05.00510.1016/j.tcb.2017.05.005 ↗
70. 10.1016/j.jaut.2018.02.01010.1016/j.jaut.2018.02.010 ↗
71. 10.1016/j.cca.2017.09.01910.1016/j.cca.2017.09.019 ↗
72. 10.1038/nature0771010.1038/nature07710 ↗
73. 10.3389/fimmu.2022.84173210.3389/fimmu.2022.841732 ↗
74. 10.4110/in.2020.20.e3910.4110/in.2020.20.e39 ↗
75. 10.1016/j.trecan.2021.09.00310.1016/j.trecan.2021.09.003 ↗
76. 10.1038/s41598-017-09767-010.1038/s41598-017-09767-0 ↗
77. 10.1038/cddis.2014.37510.1038/cddis.2014.375 ↗
78. 10.1016/j.jaut.2019.05.01410.1016/j.jaut.2019.05.014 ↗
79. 10.3389/fimmu.2021.72145310.3389/fimmu.2021.721453 ↗
80. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
81. 10.1084/jem.2021051810.1084/jem.20210518 ↗
82. 10.1038/ncb306410.1038/ncb3064 ↗
83. 10.1038/s41392-021-00804-z10.1038/s41392-021-00804-z ↗
84. 10.1038/s41467-021-27948-410.1038/s41467-021-27948-4 ↗
85. 10.1155/2021/424625510.1155/2021/4246255 ↗
86. 10.18632/aging.20464110.18632/aging.204641 ↗
87. 10.1167/iovs.12-1032510.1167/iovs.12-10325 ↗
88. 10.3389/fimmu.2019.0281410.3389/fimmu.2019.02814 ↗
89. 10.1016/j.freeradbiomed.2010.10.68710.1016/j.freeradbiomed.2010.10.687 ↗
90. 10.1016/j.cub.2011.09.04010.1016/j.cub.2011.09.040 ↗
91. 10.1096/fj.202100273RR10.1096/fj.202100273RR ↗
92. 10.1038/s41392-022-01229-y10.1038/s41392-022-01229-y ↗
93. 10.1016/j.autrev.2021.10286710.1016/j.autrev.2021.102867 ↗
94. 10.3390/ijms2218969910.3390/ijms22189699 ↗
95. 10.1038/s41556-023-01091-210.1038/s41556-023-01091-2 ↗
96. 10.3390/ijms2207337710.3390/ijms22073377 ↗
97. 10.1073/pnas.051083710310.1073/pnas.0510837103 ↗
98. 10.1016/j.yexcr.2018.12.02710.1016/j.yexcr.2018.12.027 ↗
99. 10.1016/j.jaut.2017.09.00710.1016/j.jaut.2017.09.007 ↗
100. 10.1016/j.immuni.2012.11.01610.1016/j.immuni.2012.11.016 ↗